Table 2.
Independent associations with all-cause mortality and cumulative incidence of cardiovascular mortality in individuals with type 2 diabetes
| All-cause mortality | |||
|---|---|---|---|
| Baseline parameter | Hazard ratio | P | 95% CI |
| 24-h urinary sodium excretion (per 100 mmol/day) | 0.72 | 0.017 | 0.55–0.94 |
| Age (per decade) | 1.05 | <0.001 | 1.03–1.07 |
| Male sex (yes/no) | 1.51 | 0.013 | 1.09–2.09 |
| Pre-existing CVD (yes/no) | 1.85 | 0.001 | 1.30–2.64 |
| eGFR (per 10 mL/min/1.73 m2) | 0.988 | 0.002 | 0.980–0.996 |
| Atrial fibrillation (yes/no) | 1.97 | <0.001 | 1.39–2.81 |
| Log10 AER | 1.71 | <0.001 | 1.38–2.12 |
| Systolic blood pressure (mmHg) | 0.986 | 0.015 | 0.974–0.997 |
| Diabetes duration (decades) |
1.02 |
0.010 |
1.01–1.04 |
| Cardiovascular mortality | |||
| Baseline parameter |
Sub-hazard ratio |
P |
95% CI |
| 24-h urinary sodium excretion (per 100 mmol/day) | 0.65 | 0.026 | 0.44–0.95 |
| Male sex (yes/no) | 1.93 | 0.011 | 1.17–3.20 |
| Pre-existing CVD (yes/no) | 1.88 | 0.014 | 1.14–3.11 |
| eGFR (per 10 mL/min/1.73 m2) | 0.985 | 0.001 | 0.98–0.99 |
| Atrial fibrillation (yes/no) | 2.78 | <0.001 | 1.71–4.53 |
| Log10 AER | 1.76 | <0.001 | 1.28–2.42 |
| Systolic blood pressure (mmHg) | 0.97 | <0.001 | 0.96–0.99 |
| Diabetes duration (decades) | 1.05 | <0.001 | 1.02–1.08 |
All-cause mortality: independent associations with all-cause mortality in individuals with type 2 diabetes in a multivariate Cox model. The model explained 52% of the variation in all-cause mortality (95% CI 0.42– 0.64) and was well specified (Harrell’s C: 0.79; PH test: P = 0.136; goodness-of-fit test: P ≥ 0.37). PH, proportional hazard. Cardiovascular mortality: independent associations with the cumulative incidence of cardiovascular mortality in individuals with type 2 diabetes in the Fine and Gray (proportional hazards) model after accounting for the competing risk of noncardiovascular death.